Brief: Piramal Pharma Says US FDA Issues Form-483 With 7 Observations To Morpeth UK Facility
14/09/2026 15:23
BRIEF-Piramal Pharma Says US FDA Issues Form-483 With 7 Observations To Morpeth UK Facility Sept 14 (Reuters) - Piramal Pharma Ltd PIRM.NS:
US FDA CONDUCTS GMP INSPECTION OF PIRAMAL PHARMA MORPETH UK FACILITY FROM SEPT 3-11
US FDA ISSUES FORM-483 WITH 7 OBSERVATIONS TO MORPETH UK FACILITY
Source text: ID:nBSEmz79Q
Further company coverage: PIRM.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma (Mumbai) Says Commercial Arrangement With Bayer Pharmaceuticals To Expire On December 31, 2026
Brief: Piramal Pharma (Mumbai) Says Tax Authority Confirms Demand Of 40.6 Million Rupees And Imposes Equivalent Penalty
India's Piramal Pharma falls after US FDA observations at UK facility
Brief: Piramal Pharma Says US FDA Issues Form-483 With 7 Observations To Morpeth UK Facility
Brief: Piramal Pharma Approves Exercise Of Call Option For Acquisition Of Additional 41% Equity In Yapan Bio